Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Compatibility

Sanofi

Status and phase: Completed; Phase 3

Conditions: Hygiene

Treatments: Drug: Dermacyd PH_DETINBACK (Lactic Acid)

Study type: Interventional

Funder types: Industry

Identifiers

NCT00785681

LACAC_L_04302

Details and patient eligibility

About

The purpose of this study is to demonstrate the absence of irritation potential (primary dermical irritability and cumulated dermical irritability) and allergy (sensibilization) of the product Dermacyd PHDETINBACK Sweet Flower.

Enrollment: 53 patients

Sex: Female

Ages: 18 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Phototype Skin I,II, III e IV

• Integral skin test in the region;
• Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion;

Exclusion criteria

• Lactation or gestation
• Use of Antiinflammatory and/or immunosuppression drugs
• Personnel history of atopy;
• History of sensitivity or irritation for topic products;
• Active cutaneous disease;
• Use of new drugs or cosmetics during the study

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Trial design

Primary purpose: Supportive Care

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

53 participants in 1 patient group

1

Experimental group

Description:

Dermacyd PH_DETINBACK (Lactic Acid)

Treatment:

Drug: Dermacyd PH_DETINBACK (Lactic Acid)